“Nourish the Upright and the Mass Dissolves”: What a Pathologist Makes of 養正積自除

There is an old principle in Korean Traditional Medicine (KTM), the traditional healing system of Korea also known as Hanbang (한방): nourish the upright and the accumulation dissolves on its own (養正積自除, 양정적자제). The idea is that you do not always have to attack a mass directly — strengthen the body’s own upright vitality (zheng qi, 정기 正氣) and the accumulation (積, ji) can resolve by itself. To a modern ear this sounds either mystical or naive. As a pathologist who also practices KTM, I find it neither — but only once you say precisely where it applies and where it does not. The honest version of this principle lives entirely in the difference between a benign tumor and a malignant one.

The Principle: Strengthen the Host, Not Just Attack the Mass

Modern oncology is built, understandably, around attacking the tumor: cut it out, poison it, irradiate it. KTM has always carried a second instinct alongside this, captured in the broader principle of supporting the upright and dispelling the pathogen (부정거사, 扶正祛邪) — that you treat illness not only by striking at the disease but by reinforcing the host so the body can prevail. 養正積自除 is that instinct applied specifically to masses. Where conquest-minded medicine asks how to destroy the accumulation, this principle asks a different question: what if you strengthened the terrain the accumulation depends on, and let the body do the dissolving?

I have argued elsewhere that treating total conquest of a tumor as the only goal can be the wrong target. 養正積自除 is the constructive other half of that argument — not “stop fighting the cancer,” but “do not forget to build up the patient.” The interesting question, and the one a pathologist is actually equipped to answer, is when that second instinct is biologically sound and when it is wishful. The answer turns on what kind of mass you are talking about.

Why It Cannot Dissolve a Benign Tumor

Let me start with the limit, because stating it plainly is what keeps the rest honest. 養正積自除 cannot make a benign tumor disappear, and any claim that it can should be treated with suspicion.

A benign tumor — a lipoma, a fibroid, a simple cyst — is, in pathological terms, a bounded and largely finished structure. It has clear margins, often a capsule, and it sits in the tissue as a discrete object that has stopped doing much except occupy space. It does not depend, moment to moment, on a dynamic struggle with the host; it is closer to a wall that has already been built. You can make the patient as robust as you like, and the wall does not melt. Strengthening the host does not reach into a self-contained lump and dismantle it. This is exactly the kind of overpromise that discredits traditional medicine in Western eyes, and it deserves to — a bounded benign mass is a job for watchful waiting or, if it must go, the surgeon, not for nourishing the upright.

Why It Is Coherent for Malignancy

Malignancy is a different kind of thing entirely, and this is where the principle stops being naive. A cancer is not a finished structure sitting quietly in the tissue. It is a living, dividing, invading process — and, crucially, a process that is not self-sufficient. It is locked in a continuous relationship with the body around it.

From the pathology I teach, that dependence is concrete. A growing tumor must recruit the host’s blood supply to feed itself. It must evade or exhaust the host’s immune surveillance. It bends the surrounding tissue — the microenvironment — to its own metabolic needs, and it competes with the host for resources. A malignant tumor is therefore never just a lump; it is a lump in a relationship, and that relationship runs through the host’s vascular, immune, and metabolic state. Change the host, and you change one side of an equation the cancer cannot solve alone.

It helps to be concrete about what “nourishing the upright” actually means, because the phrase can sound like vague Eastern poetry. Among its meanings — and the one that matters most here — is the strengthening and normalizing of immune function. Note the second word: the aim is not simply to crank immunity ever higher, but to restore it toward proper working order, since an immune system can fail by being too weak to clear abnormal cells just as it can err by turning on the body’s own tissue. That framing maps onto malignancy with some precision. A cancer survives in part by escaping immune surveillance — hiding from, suppressing, or exhausting the very defenses meant to detect and destroy abnormal cells. To the extent that supporting the upright restores that surveillance toward normal function, it is acting on one of the exact mechanisms a tumor depends on to persist. I offer this as the most legible reading of an old idea, not as a claim that the classical term simply equals “immune function” — but the overlap is real, and it is where the principle stops sounding mystical and starts sounding mechanistic.

This is why nourish the upright is coherent for malignancy in a way it simply is not for a benign mass. If the host’s vitality genuinely strengthens — immune function, metabolic resilience, the body’s whole capacity to resist — then the conditions a cancer needs to keep invading and growing can tighten against it. The plausible outcomes are not “the lump vanishes overnight” but rather growth stalling, or in some cases regression: the tumor losing ground because the terrain stopped cooperating. I want to be careful and exact here. This is a statement of biological coherence and clinical reasoning — it rhymes with what modern science is learning about the tumor microenvironment and immune surveillance, but I am not claiming the old principle has been validated by that science, and the connection should be held as interpretive rather than proven. What I can say as a pathologist is that the logic is not absurd. For a process that lives off its host, strengthening the host is a real lever.

What This Is Not

Everything in this essay collapses into danger if one distinction is lost, so let me make it unmissable: this is not a case for treating cancer with nourishment instead of medicine. 養正積自除 is a complementary axis, not a replacement for standard oncologic care. Surgery, chemotherapy, radiation, and modern targeted and immune therapies are the tools that attack the malignant process directly, and for most cancers they are the difference between life and death. Nothing here is a reason to delay, decline, or stop them.

What the principle offers is the other half of the picture that pure conquest tends to neglect — the patient as host. A body kept strong, nourished, and resilient through treatment is not a sentimental nicety; it is the side of the equation that determines whether the patient can tolerate therapy, recover between cycles, and keep their own defenses in the fight. The honest framing is “support the host alongside attacking the disease,” and the claims should stay there. The possibility that strengthening the host can stall or shrink a malignancy is drawn from how cancer behaves and from clinical observation; it is not a guarantee of cure, and it has not been established by controlled trials. Anyone who sells nourishing the upright as a standalone cancer cure has crossed from this principle into something I would warn you away from.

What This Means for You

If you or someone you love is facing cancer, the foundation is unambiguous: the treatment plan belongs with the oncology team, and the standard therapies come first. But the old principle still has something true to offer inside that plan. It says, in effect, that the patient is not merely the battlefield on which the tumor is attacked — the patient is an active party in the outcome, and their vitality is part of the treatment, not a distraction from it. Nutrition, strength, rest, and the deep reserves the body draws on are worth protecting fiercely, precisely because, for a disease that lives off its host, the host’s condition is never neutral. Strengthen the patient, support the standard care, and you are working both sides of the equation at once — which is, in the end, what 養正積自除 was pointing at all along.

In Summary

養正積自除 — nourish the upright and the mass dissolves on its own — is the tumor-facing form of KTM’s instinct to strengthen the host rather than only attack the disease. A pathologist can place it precisely. It cannot dissolve a benign tumor, which is a bounded, finished structure that no amount of host vitality will melt. But it is genuinely coherent for malignancy, because a cancer is not a static lump but a living process dependent on its host’s blood supply, immune state, and metabolism — and because nourishing the upright, in one of its concrete meanings, is the strengthening and normalizing of the very immune surveillance a tumor works to escape. So strengthening the host can plausibly stall or even shrink it. This is a complement to standard cancer treatment, never a substitute, and a statement of biological coherence rather than a promise of cure. Attack the disease with the full force of modern medicine, and build up the patient at the same time. The old principle was pointing at the half of the equation conquest forgets.

Related reading: Cancer in KTM: Why Total Conquest Is the Wrong Goal · How Should an Ordinary Person Approach Korean Medicine?